Literature DB >> 23245924

PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery.

Yong Qian1, Yuan Zha, Bing Feng, Zhiqing Pang, Bo Zhang, Xiyang Sun, Jinfeng Ren, Chi Zhang, Xiayan Shao, Qizhi Zhang, Xinguo Jiang.   

Abstract

Phage-displayed TGN peptide-decorated polymeric micelle-like polyplexes based on pegylated poly(2-(dimethylamino) ethyl methacrylate) (PEG-PDMAEMA) were prepared for efficient brain-targeted gene delivery. The diblock copolymers Methoxy-PEG-PDMAEMA and Maleimide-PEG-PDMAEMA were synthesized by the atom transfer radical polymerization method. The TGN ligand, a 12-amino acid peptide that could facilitate blood-brain barrier (BBB) targeting, was conjugated to the PEG terminus of the copolymer via a maleimide-mediated covalent binding procedure. TGN-PEG-PDMAEMA was complexed with plasmid DNA to yield polyplexes. The physiochemical properties of the polyplexes, such as morphology, particle size, zeta potential, cytotoxicity and DNA complex formation ability, were studied prior to the successful in vitro and in vivo transfection. The TGN-PEG-PDMAEMA/DNA polyplexes maintained their stable nano-size, were characterized by good condensation capacity and low toxicity and even provided higher cellular uptake than the unmodified polyplexes (PEG-PDMAEMA/DNA polyplexes). Confocal microscopy studies showed that the DNA of TGN-PEG-PDMAEMA/DNA polyplexes entered into the nuclei through the endosome/lysosome pathway. The transfection efficiency of TGN-modified polyplexes was higher than that of unmodified polyplexes both in vitro and in vivo. The results obtained from frozen sections indicated the widespread expression of an exogenous gene in the mouse brain after intravenous injection. Therefore, the results demonstrate that the TGN-decorated PEG-PDMAEMA developed in this study could be utilized as a potential vehicle for gene delivery to the brain.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23245924     DOI: 10.1016/j.biomaterials.2012.11.050

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  11 in total

1.  Targeted Gene Delivery to MCF-7 Cells Using Peptide-Conjugated Polyethylenimine.

Authors:  Ahad Mokhtarzadeh; Hamideh Parhiz; Maryam Hashemi; Sara Ayatollahi; Khalil Abnous; Mohammad Ramezani
Journal:  AAPS PharmSciTech       Date:  2015-02-05       Impact factor: 3.246

Review 2.  Overcoming barriers in non-viral gene delivery for neurological applications.

Authors:  Aaron Tasset; Arjun Bellamkonda; Wenliang Wang; Ilya Pyatnitskiy; Deidra Ward; Nicholas Peppas; Huiliang Wang
Journal:  Nanoscale       Date:  2022-03-10       Impact factor: 8.307

Review 3.  Nanocarrier-based therapies for CNS tumors.

Authors:  Toral R Patel
Journal:  CNS Oncol       Date:  2014-03

Review 4.  Polymer-mediated gene therapy: Recent advances and merging of delivery techniques.

Authors:  Janelle W Salameh; Le Zhou; Sarah M Ward; Cristiam F Santa Chalarca; Todd Emrick; Marxa L Figueiredo
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-12-02

Review 5.  Multifunctional polymeric micelles for delivery of drugs and siRNA.

Authors:  Aditi M Jhaveri; Vladimir P Torchilin
Journal:  Front Pharmacol       Date:  2014-04-25       Impact factor: 5.810

6.  OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma.

Authors:  Pei-jian Yue; Lei He; Shu-wei Qiu; Yi Li; Yi-ji Liao; Xiang-pen Li; Dan Xie; Ying Peng
Journal:  Mol Cancer       Date:  2014-08-13       Impact factor: 27.401

7.  Core-shell nanocarriers with high paclitaxel loading for passive and active targeting.

Authors:  Zhu Jin; Yaqi Lv; Hui Cao; Jing Yao; Jianping Zhou; Wei He; Lifang Yin
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

Review 8.  Non-Viral Nucleic Acid Delivery Strategies to the Central Nervous System.

Authors:  James-Kevin Y Tan; Drew L Sellers; Binhan Pham; Suzie H Pun; Philip J Horner
Journal:  Front Mol Neurosci       Date:  2016-11-01       Impact factor: 5.639

9.  SRL-Coated PAMAM Dendrimer Nano-Carrier for Targeted Gene Delivery to the Glioma Cells and Competitive Inhibition by Lactoferrin.

Authors:  Amir Zarebkohan; Farhood Najafi; Hamid Reza Moghimi; Mohammad Hemmati; Mohammad Reza Deevband; Bahram Kazemi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

10.  Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization.

Authors:  Huile Gao; Zhi Yang; Shuang Zhang; Shijie Cao; Shun Shen; Zhiqing Pang; Xinguo Jiang
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.